Britain's Royal Society

Only five years later, the whole world was struck by a coronavirus pandemic - and countries were desperately struggling to secure vaccines for their populations.

Unfortunately, the EU did not understand the vaccine race and opted for a "no urgency" attitude. The UK, on the other hand, put a venture capitalist specializing in biosciences in charge of its vaccine program.